Reza Fathi
Technik-/Wissenschafts-/F&E-Leiter bei REDHILL BIOPHARMA LTD.
Vermögen: 82 477 $ am 31.05.2024
Aktive Positionen von Reza Fathi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| REDHILL BIOPHARMA LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2010 | - |
Karriereverlauf von Reza Fathi
Ehemalige bekannte Positionen von Reza Fathi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| XTL BIOPHARMACEUTICALS LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 | - |
VivoQuest, Inc.
 VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Geschäftsführer | 01.01.2000 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | - | |
| Harvard Medical School | Corporate Officer/Principal | 01.01.1998 | 01.01.2000 |
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Corporate Officer/Principal | 01.01.1991 | 01.01.1998 |
Ausbildung von Reza Fathi
| Rutgers State University of New Jersey | Doctorate Degree |
| Texas Tech University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Israel | 3 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| REDHILL BIOPHARMA LTD. | Health Technology |
| XTL BIOPHARMACEUTICALS LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
VivoQuest, Inc.
VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Health Technology |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Commercial Services |
- Börse
- Insiders
- Reza Fathi
- Erfahrung
